A kind of production method of nadroparin calcium
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 山东辰龙药业有限公司
- Publication Date
- 2015-08-26
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The invention relates to the field of biomedicine, in particular to a method for producing Nadroparin calcium (Nadroparin). Background technique
[0002] Heparin (unfractionated heparin) is a highly sulfated glycosaminoglycan that has anticoagulant effects both in vivo and in vitro. However, unfractionated heparin has defects such as low bioavailability, large side effects, and frequent administration, and its replacement product, low-molecular-weight heparin such as nadroparin calcium, not only has better antithrombotic effect than unfractionated heparin, but also has high bioavailability, long half-life in vivo, Small bleeding tendency and other advantages. The anticoagulant activity of heparin is divided into two categories: antithrombotic activity (FXa) and anticoagulant (FIIa) activity. In the process of antithrombosis, both anti-FXa activity and anti-FIIa activity are necessary. The measuring standard of FXa / FIIa is expressed by the value of an...